Test and Treat Limited
Test&Treat targets commercialise point of care tests for the rapid detection of bacterial infections and subsequent antibiotic sensitivity (AS) analysis.
- Stage Prototype Ready
- Industry Biotechnology
- Location Cambridge, UK
- Currency GBP
- Founded September 2017
- Employees 6
- Incorporation Type C-corp
- Website testandtreat.co.uk
Company Summary
Test and Treat addresses one of the major risks in healthcare through its point of care (PoC) tests for the rapid detection of bacterial infections and subsequent antibiotic sensitivity (AS) analysis. The company will seek initial sales traction in the relatively lightly regulated animal market with tests for UTIs, mastitis and TB. The human market will be targeted through licensing of its patented technology to global diagnostics companies.
Team
-
CEOOver 35 years’ experience in the diagnostics industry, spanning instrument development, bioluminescence technology, IVD regulatory compliance (CE marking and FDA), QA and manufacturing of IVD’s. His knowledge of ATP Bioluminescent technology is significant, being Development Director for Celcis International for 5 years. He is very experienced in start-up businesses as well as mergers and acquisitions.
-
Ron TurnerFounder and Technical DirectorHas owned his own businesses including a PoC company and a clinical laboratory; worked in Technical Marketing and Business Management for 2 major diagnostic companies. He is a UK-born clinical laboratory scientist, now based in the UK. He is the inventor of the owned IP and has worked as a clinical laboratory scientist in the UK NHS and the private sector (both the UK and USA) and as a Laboratory Director of a clinical laboratory.
-
Professor John WainNon Executive DirectorJohn Wain is Professor of Medical Microbiology at the University of East Anglia, the CSO and director for Discuva and Bactevo Ltd. and founding editor of the Journal of Infection in Developing Countries. He is a bacteriologist and international authority on Salmonella and other gastrointestinal pathogens with over 30 years' experience in the identification of bacterial pathogens and antibiotic resistance.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.